ALEX shareholder (NYSE: ALEX) files Form 144 to sell 700 shares
Rhea-AI Filing Summary
A shareholder of ALEX filed a Form 144 notice to sell up to 700 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $14,595.00 and a stated sale date of 12/10/2025. The issuer has 72,758,460 shares outstanding; this is a baseline figure, not the amount being sold. The 700 shares were acquired from the issuer on 02/01/2023 as compensation.
Over the past three months, the same selling account, The Meredith J Ching Revocable Living Trust, sold three separate blocks of 700 common shares each, on 09/10/2025, 10/10/2025, and 11/10/2025, generating gross proceeds of $13,128.78, $11,728.57, and $10,837.33, respectively.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for ALEX disclose?
The Form 144 filing discloses that a shareholder intends to sell up to 700 common shares of ALEX stock through UBS Financial Services on the NYSE, with an aggregate market value of $14,595.00 and an expected sale date of 12/10/2025.
How many ALEX shares are planned to be sold under this Form 144?
The notice covers the proposed sale of 700 common shares of ALEX.
How were the ALEX shares being sold acquired by the shareholder?
The 700 shares to be sold were acquired on 02/01/2023 directly from the issuer as compensation.
What prior ALEX share sales has the trust reported in the last 3 months?
The Meredith J Ching Revocable Living Trust reported selling 700 common shares on each of 09/10/2025, 10/10/2025, and 11/10/2025, for gross proceeds of $13,128.78, $11,728.57, and $10,837.33, respectively.
How many ALEX shares are outstanding according to the Form 144?
The Form 144 states that there are 72,758,460 common shares outstanding for the issuer.
Which broker and exchange are involved in the planned ALEX share sale?
The planned sale of 700 ALEX common shares is through UBS Financial Services, Inc., and the shares are listed for trading on the NYSE.